Copyright
©The Author(s) 2016.
World J Transplant. Dec 24, 2016; 6(4): 774-789
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.774
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.774
Search # | Keywords and number of records identified |
Search #1 | Organ transplantation (110179) |
Search #2 | Transplantation conditioning (7738) |
Search #3 | Transplant recipients (195) |
Search #4 | “Transplant recipient$” (27594) |
Search #5 | 1 or 2 or 3 or 4 (122169) |
Search #6 | Exercise/or Exercise Therapy/or exercise$ (192344) |
Search #7 | Rehab$/or rehabilitation (151761) |
Search #8 | Resistance training/or “physical education and training”/or training (181282) |
Search #9 | “Physical activity” (47446) |
Search #10 | Physical exertion (11451) |
Search #11 | 6 or 7 or 8 or 9 or 10 (474657) |
Search #12 | 5 and 11 (2399) |
Search #13 | Heart or lung or kidney or pancreas or liver (1433618) |
Search #14 | 12 and 13 (2200) |
Search #15 | Limit 14 to humans (2156) |
Search #16 | Limit 14 to animals (76) |
Search #17 | 15 not 16 (2121) |
Search #18 | Limit 17 to randomized controlled trial (60) |
Ref. | Country | Year | Organ | Time-post transplant (wk) | Treatment duration (wk) | Randomized patients1 | Exercise intervention | Comparison |
Braith et al[5] | United States | 1996 | Heart | > 8 | 24 | 16 | Lumbar extension 1 d/wk; variable resistance exercises 2 d/wk | Usual care |
Braith et al[4] | United States | 1998 | Heart | > 8 | 24 | 162 | Lumbar extension 1 d/wk; variable resistance exercises 2 d/wk | Usual care |
Kobashigawa et al[15] | United States | 1999 | Heart | > 2 | 26 | 27 | Individualized cardiac rehabilitation (strengthening, flexibility, and moderate aerobic exercises) 1-3 d/wk | Usual care (unstructured therapy at home) |
Painter et al[16] | United States | 2002 | Kidney | 4-8 | 48 | 167 | Independent home-based exercise 4 d/wk | Usual care |
Mitchell et al[17] | United States | 2003 | Lung | > 8 | 26 | 16 | Lumbar extension resistance exercise 1 d/wk and walking program | Usual care (walking program) |
Painter et al[18] | United States | 2003 | Kidney | > 4 | 48 | 96 | Independent home-based exercise 4 d/wk | Usual care |
Braith et al[19] | United States | 2005 | Heart | > 8 | 24 | 15 | Variable resistance exercises 2 d/wk | Usual care |
Juskowa et al[20] | Poland | 2006 | Kidney | > 0.5 | 4-5 | 69 | Strength exercise training 7 d/wk | Usual care |
Krasnoff et al[3] | United States | 2006 | Liver | > 8 | 40 | 151 | Cardiovascular exercise training 3 d/wk | Usual care |
Bernardi et al[21] | Italy | 2007 | Heart | > 24 | 24 | 26 | Stationary bicycle; 30 min/5 d per week | Usual care |
Karapolat et al[22] | Turkey | 2007 | Heart | Mean 14-17 | 8 | 38 | Hospital-based exercise program (flexibility, stretching, aerobic, strengthening, breathing, relaxation) 3 d/wk | Home-based exercise program (flexibility, stretching, aerobic, strengthening, breathing, relaxation) 3 d/wk |
Braith et al[23] | United States | 2008 | Heart | > 8 | 12 | 20 | Aerobic treadmill exercise | Usual care |
Karopola et al[24] | Turkey | 2008 | Heart | Mean 14-17 | 8 | 383 | Hospital-based exercise program (flexibility, stretching, aerobic, strengthening, breathing, relaxation) 3 d/wk | Home-based exercise program (flexibility, stretching, aerobic, strengthening, breathing, relaxation) 3 d/wk |
Pierce et al[25] | United States | 2008 | Heart | > 8 | 12 | 20 | Aerobic exercise training | Usual care |
Wu et al[26] | Taiwan | 2008 | Heart | > 52 | 8 | 37 | Resistance and aerobic training 3 d/wk | Usual care |
Haykowsky et al[27] | Canada | 2009 | Heart | > 26 | 12 | 23 | Aerobic 5 d/wk and strength training 2 d/wk | Usual care |
Mandel et al[28] | United States | 2009 | Liver | 6-12 | 12 | 50 | Targeted lower body resistance strengthening exercise 3-4 d/wk | Usual care (walking program) |
Hermann et al[29] | Denmark | 2011 | Heart | > 52 | 8 | 27 | Aerobic interval training program 3 d/wk | Usual care |
Ihle et al[30] | Germany | 2011 | Lung | > 52 | 4 | 60 | Inpatient rehabilitation (exercise training 4 d/wk and aerobic session 5 d/wk) | Outpatient physiotherapy |
Christensen et al[31] | Denmark | 2012 | Heart | Mean 84 | 8 | 4 | High-intensity aerobic interval training 3 d/wk | Usual care |
Langer et al[2] | Belgium | 2012 | Lung | 1-6 | 12 | 40 | Aerobic and resistance training 3 d/wk | Usual care |
Nytrøen et al[32] | Norway | 2012 | Heart | 52-416 | 52 | 52 | High-intensity aerobic interval training 3 d/wk | Usual care |
Rustad et al[33] | Norway | 2012 | Heart | 52-416 | 12 | 52 | High-intensity aerobic interval training 3 d/wk | Usual care |
Kawauchi et al[34] | Brazil | 2013 | Heart | < 1 | to hospital discharge | 22 | 10-phase incremental exercise program (breathing, active resistance exercises, aerobic exercises, stretching) | Institution exercise routine (breathing, stretching walking) 5 d/wk |
Kouidi et al[35] | Greece | 2013 | Kidney | > 52 | 26 | 24 | Aerobic exercise and strength training 4 d/wk | Usual care |
Nytrøen et al[36] | Norway | 2013 | Heart | 52-416 | 52 | 525 | High-intensity aerobic interval training 3 d/wk | Usual care |
Dall et al[37] | Denmark | 2014 | Heart | > 52 | 12 (5 mo washout) | 17 | High-intensity aerobic interval training 3 d/wk | Moderate biking exercise 3 d/wk |
Monk-Hansen et al[38] | Denmark | 2014 | Heart | > 52 | 8 | 30 | High intensity training 3 d/wk | Usual care |
Pascoalino et al[39] | Brazil | 2015 | Heart | > 52 | 12 | 42 | Endurance exercise training 3 d/wk | Usual care |
Pooranfar et al[40] | Iran | 2013 | Kidney | 104-156 | 10 | 44 | Aerobic and resistance training 3 d/wk | Usual care |
Riess et al[41] | Canada | 2013 | Kidney | > 26 | 12 | 31 | Endurance and strength training 2 d/wk | Usual care |
Tzvetanov et al[42] | United States | 2014 | Kidney | > 4 | 52 | 17 | Resistance exercise training 2 d/wk (as well as behaviour and nutrition) | Usual care |
Dall et al[43] | Denmark | 2015 | Heart | > 52 | 12 (5 mo washout) | 176 | High-intensity aerobic interval training 3 d/wk | Moderate biking exercise 3 d/wk |
Greenwood et al[44] | England | 2015 | Kidney | < 52 | 12 | 60 | Home-based aerobic training and resistance training 3 d/wk | Usual care |
Karelis et al[45] | Canada | 2015 | Kidney | 6-8 | 16 | 24 | Resistance training 3 d/wk (once a week in hospital and 2 × /week at home) | Usual care (no exercise) |
Ref. | Year | Organ group | Primary outcome measures | Secondary outcome measures |
Braith et al[5] | 1996 | Heart | Bone mineral density (body and regional: Femur neck, lumbar vertebra) | Bone mineral content Total bone calcium Acute rejection episodes |
Braith et al[4] | 1998 | Heart | Body mass Fat-free mass Fat mass Muscle strength (upper and lower body) | Percent body fat Acute rejection episodes |
Kobashigawa et al[15] | 1999 | Heart | Blood pressure (peak and resting) Heart rate (peak and resting) Anaerobic threshold Exercise duration (to exhaustion) Peak ventilation Peak VO2 Peak workload Ventilatory equivalent for carbon dioxide and oxygen | Muscle strength (lower limb) |
Painter et al[16] | 2002 | Kidney | Body mass index Body weight Fat mass/body fat Lean tissue mass Percent body fat Blood pressure (peak) Muscle strength (quadriceps) Peak ventilation Peak VO2 SF-36 | Self-reported activity level (frequency, type, length, and intensity of exercise) Blood creatinine Blood urea nitrogen levels Hematocrit Hemoglobin Bone mineral density Peak workload Rating of perceived exertion (Borg) Peak respiratory exchange ratio Immunosuppression use (type, dose) |
Mitchell et al[17] | 2003 | Lung | Bone mineral density (lumbar spine) | Acute rejection episodes Muscle strength (lumbar extensor) |
Painter et al[18] | 2003 | Kidney | Cholesterol (TC, HDL) Body mass index Total CVD risk (Framingham) Blood pressure Peak workload (METs) | Blood lipids Incidence of diabetes Smoking status |
Braith et al[19] | 2005 | Heart | Muscle composition (fiber types) Muscle metabolic enzyme activity | Muscle strength (upper and lower body) |
Juskowa et al[20] | 2006 | Kidney | Blood lipids Cholesterol (TC, HDL, LDL) Body mass index | Blood calcium level Blood creatinine Blood electrolytes Blood glucose Blood phosphorus Blood protein levels (albumin, fibrinogen, total protein level) Enzyme levels (alanine transferase, alkaline phosphatase, aspartate aminotransferase) Folate concentrations Hemoglobin Interleukin-18 Total-homocysteine Vitamin B12 Blood pressure Muscle strength (upper limbs) Peak expiratory flow |
Krasnoff et al[3] | 2006 | Liver | Body mass index Body weight Bone mineral content Bone mineral density Fat mass/body fat Lean tissue mass Percent body fat Muscle strength (quadriceps) Peak VO2 SF-36 Peak respiratory exchange ratio Nutritional intake (Block-95 - calories/day; protein, carb and fat calories) | Rating of perceived exertion (Borg) |
Bernardi et al[21] | 2007 | Heart | Baroceptor control of blood pressure Baroceptor control of heart rate | Blood pressure; Heart rate Neck pressure RR interval Anaerobic threshold CO2 production Exercise duration (to exhaustion) Peak ventilation Peak VO2; Peak workload Ventilatory equivalent for CO2 and oxygen |
Karapolat et al[22] | 2007 | Heart | Peak VO2 Beck depression inventory SF-36 State-trait anxiety inventory | |
Braith et al[23] | 2008 | Heart | Endothelial function (flow-mediated dilation) | Blood glucose Blood lipids Cholesterol (TC, HDL, LDL) Oxidative stress-induced lipid peroxidation Plasma norepinephrine Serum metabolic and hematologic indicators Body mass Acute rejection episodes Blood pressure (resting and peak) Brachial artery diameter Exercise duration (to exhaustion) Peak VO2 |
Karapolat et al[24] | 2008 | Heart | Chronotropic response index Heart rate recovery Heart rate reserve Peak VO2 | Duke Treadmill Score |
Pierce et al[25] | 2008 | Heart | C-reactive protein Interleukin-6 Serum metabolic profile Soluble cell adhesion molecules (sICAM-1) Tumour necrosis factor-alpha Muscle vasodilation (forearm and calf) | Blood glucose Cholesterol (TC, HDL, LDL) Cytomegalovirus IgG status White blood cell levels Acute rejection episodes Blood pressure (resting) Heart rate (peak and resting) Exercise duration (to exhaustion) Rating of perceived exertion (Borg) Peak respiratory exchange ratio |
Wu et al[26] | 2008 | Heart | Muscle endurance (quadriceps) Muscle strength (quadriceps) Peak VO2 World Health Organization Questionnaire on Quality of Life - BREF | Daily physical activity Blood pressure Heart rate (resting and peak) Nutritional intake (caloric intake questionnaire) Peak ventilation Peak workload Rating of perceived exertion (Borg) |
Haykowsky et al[27] | 2009 | Heart | Peak VO2 | Lean tissue mass (total and leg) Blood pressure (peak) Endothelial function (endothelial-dependent vasodilation, endothelial-independent vasodilation, reactive hyperemia index) Heart rate (peak) Left ventricular systolic function Muscle strength (upper and lower body) Peak power output Peak respiratory exchange ratio |
Mandel et al[28] | 2009 | Liver | 6MWD Muscle strength (lower body) Chronic liver disease questionnaire (CLDQ) SF-36 (physical function/limitations) | |
Hermann et al[29] | 2011 | Heart | Peak VO2 | Blood creatinine Blood glucose; Blood lipids Blood protein levels (adiponectin, MR-proANP, NT-proBNP, provasopressin/copeptin) Cholesterol Hemoglobin High sensitive C-reactive protein Interleukin-6 Serum insulin Tumour necrosis factor-alpha Body mass index; Body weight Hip-waist ratio Blood pressure (resting) Brachial artery diameter Endothelial function (flow-mediated vasodilation, nitroglycerin-induced vasodilation) Heart rate (resting) Peak power output |
Ihle et al[30] | 2011 | Lung | 6MWD Peak VO2 SF-36 St. George’s Respiratory Questionnaire | Heart rate (peak and resting) Anaerobic threshold Oxygen uptake at anaerobic threshold Peak workload Peak respiratory exchange ratio Ventilatory reserve and capacity |
Christensen et al[31] | 2012 | Heart | Hospital Anxiety and Depression Scale | Peak VO2 |
Langer et al[2] | 2012 | Lung | SF-36 Daily walking time (time spend in different postures: sedentary, standing, walking) | Daily steps Movement intensity Time spent in moderate intense activities Blood lipids Body weight Bone mineral density Blood pressure 6MWD Muscle strength (quadriceps and handgrip) Peak workload Mood status SF-36 Forced expiratory volume Respiratory muscle force Incidence of morbidity (diabetes, hyperlipidemia, hypertension, osteoporosis) |
Nytrøen et al[32] | 2012 | Heart | Peak VO2 | Blood lipids Blood protein levels (NT-proBNP) C-reactive protein Interleukin-6, 8 and 10 levels Body mass index; Body weight; % body fat Chronotropic response index Glycemic control parameters Blood pressure (peak and resting) Heart rate (peak and resting) Heart rate recovery and reserve Stroke volume (O2 pulse; resting and peak) Anaerobic threshold Exercise duration (to exhaustion) Muscle strength (quadriceps and hamstrings) Peak ventilation Rating of perceived exertion (Borg) SF-36 Visual Analog Scale (subjective difference in HRQoL) Peak respiratory exchange ratio |
Rustad et al[33] | 2012 | Heart | Echocardiographic parameters (rest and during exercise; systolic and diastolic parameters) Peak VO2 | Biochemical parameters Blood pressure Cardiac allograft vasculopathy (coronary angiography) Cardiac output Heart rate (resting and peak) Stroke volume Peak workload Peak respiratory exchange ratio |
Kawauchi et al[34] | 2013 | Heart | 6MWD Forced vital capacity Respiratory muscle force/strength | Muscle strength (upper and lower limbs) Maximum expiratory/inspiratory pressure |
Kouidi et al[35] | 2013 | Kidney | Baroreflex sensitivity Heart rate variability parameters (SDNN, rMSSD, pNN50, LF, HF, LF/HF) | Baroreflex effectiveness index Blood pressure (peak and resting) Heart rate (peak and resting) Exercise duration (to exhaustion) Peak ventilation Peak VO2 |
Nytrøen et al[36] | 2013 | Heart | Cardiac allograft vasculopathy (intravascular ultrasound and virtual histology) | Blood creatinine Blood glucose Blood lipids C-reactive protein Cholesterol (TC, HDL, LDL) Hemoglobin Interleukin-6, 8 and 10 levels Body mass index Body water (total) Body weight Bone mass Lean tissue mass Percent body fat Visceral fat scale Basal metabolic rate Glycemic control parameters Metabolic age Muscle strength (quadriceps and hamstrings) Peak VO2 |
Dall et al[37] | 2014 | Heart | Peak VO2 | Body weight Blood pressure Heart rate (peak and resting) Heart rate recovery Heart rate reserve CO2 production Peak ventilation Peak workload Peak respiratory exchange ratio |
Monk-Hansen et al[38] | 2014 | Heart | Echocardiography parameters (systolic and diastolic function) | Body mass index Blood pressure Heart rate (peak and resting) Peak VO2 Peak workload |
Pascoalino et al[39] | 2015 | Heart | Arterial stiffness (carotid-femoral pulse wave velocity) Blood pressure (ambulatory; peak and resting) | Plasma norepinephrine Heart rate (peak and resting) Anaerobic threshold CO2 production Exercise duration (to exhaustion) Peak VO2 Peak respiratory exchange ratio Respiratory compensation point |
Pooranfar et al[40] | 2013 | Kidney | Blood lipids Cholesterol (TC, HDL, LDL) Sleep quality and quantity questionnaire (self-report; Pittsburgh Sleep Quality Index) | |
Riess et al[41] | 2013 | Kidney | Peak VO2 | Cholesterol (TC, HDL) Lean tissue mass Total CVD risk (Framingham) Arterial pressure (mean) Arterial stiffness (pulse wave velocity) Arteriovenous oxygen difference (a-vO2) Blood pressure (ambulatory; peak and resting) Cardiac output Heart rate (peak); Stroke volume Systemic vascular endurance Muscle strength (lower body) Peak workload SF-36 Peak respiratory exchange ratio |
Tzvetanov et al[42] | 2014 | Kidney | Glomerular filtration rate SF-36 Adherence to training and follow-up Employment status | Blood creatinine; Blood glucose; Blood lipids Cholesterol (TC, HDL, LDL) Hemoglobin Body mass index Body weight Bone mineral content Lean tissue mass Percent body fat Arterial stiffness (carotid-femoral pulse wave velocity Blood pressure Carotid intima-media thickness Muscle strength |
Dall et al[43] | 2015 | Heart | Blood glucose Blood protein levels (adiponectin, orosomucoid, YLK 40) Interleukin-6 Serum insulin Tumour necrosis factor-alpha Arterial stiffness (augmentation index) Endothelial function (reactive hyperemia index) Hospital Anxiety and Depression Scale SF-36 | Body weight Homeostasis model assessment Heart rate (peak) Peak VO2 Peak respiratory exchange ratio |
Greenwood et al[44] | 2015 | Kidney | Muscle strength (quadriceps) | Arterial stiffness (pulse wave velocity) Blood pressure (peak and resting) Heart rate (peak and resting) STS-60 Peak VO2 Body mass index; Body weight Waist girth Glomerular filtration rate high-sensitivity C-reactive protein interleukin-6 Fetuin A Tumor necrosis factor-alpha tumor necrosis factor receptors 1 and 2 SF-36 Duke Activity Status Index |
Karelis et al[45] | 2015 | Kidney | World Health Organization-5 Well-Being Index Muscle strength index Adherence to training and follow-up (feasibility) | Body weight Body height Body mass index Waist girth Hip girth Fat mass/body fat Lean tissue mass Cholesterol (TC, HDL, LDL) Blood glucose Blood pressure Peak VO2 |
ICF component | Domain | Category | Outcome measures | Count primary1 | Organ group |
Body Function | Global mental functions | b134 | Sleep quality and quantity | 1 | Kidney |
b152 | Mood status | 0 | Lung | ||
Functions of the cardiovascular system (heart functions) | b410 | Cardiac output | 0 | Heart, kidney | |
b410 | Carotid intima-media thickness | 0 | Kidney | ||
b410 | Echocardiographic parameters | 2 | Heart | ||
b410 | Endothelial function | 2 | Heart | ||
b410 | Left ventricular systolic function | 0 | Heart | ||
b410 | RR interval | 0 | Heart | ||
b410 | Stroke volume | 0 | Heart, kidney | ||
b410 | Systemic vascular endurance | 0 | Kidney | ||
Functions of the cardiovascular system (heart rate) | b4100 | Heart rate | 1 | Heart, kidney, lung | |
b4100 | Heart rate recovery | 1 | Heart | ||
b4100 | Heart rate reserve | 1 | Heart | ||
b4100 | Heart rate variability | 1 | Kidney | ||
Functions of the cardiovascular system | b410-429 | Baroceptor control of blood pressure | 1 | Heart | |
b410-429 | Baroceptor control of heart rate | 1 | Heart | ||
b410-429 | Baroflex effectiveness index | 0 | Kidney | ||
b410-429 | Baroflex sensitivity | 1 | Kidney | ||
b410-429 | Chronotropic response index | 1 | Heart | ||
b410-429 | Total CVD risk | 1 | Kidney | ||
b410-429 | Cardiac allograft vasculopathy | 1 | Heart | ||
Functions of the cardiovascular system (blood vessel | b415 | Arterial stiffness | 3 | Heart, kidney | |
functions) | b415 | Brachial artery diameter | 0 | Heart | |
Functions of the cardiovascular system (blood | b420 | Arterial pressure | 0 | Kidney | |
pressure functions) | b420 | Blood pressure | 4 | Heart, kidney, lung | |
b420 | Neck pressure | 0 | Heart | ||
Functions of the cardiovascular system (oxygen-carrying functions of the blood) | b4301 | Arteriovenous oxygen difference | 0 | Kidney | |
Functions of the hematological and immunological | b430-439 | Biochemical parameters | 0 | Heart | |
systems | b430-439 | Blood calcium level | 0 | Kidney | |
b430-439 | Blood creatinine | 0 | Heart, kidney | ||
b430-439 | Blood electrolytes | 0 | Kidney | ||
b430-439 | Blood glucose | 1 | Heart, kidney | ||
b430-439 | Blood lipids | 2 | Heart, kidney, lung | ||
b430-439 | Blood phosphorus | 0 | Kidney | ||
b430-439 | Blood protein levels | 1 | Heart, kidney | ||
b430-439 | Blood urea nitrogen levels | 0 | Kidney | ||
b430-439 | C-reactive protein | 1 | Heart | ||
b430-439 | Cholesterol | 3 | Heart, kidney | ||
b430-439 | Folate concentrations | 0 | Kidney | ||
b430-439 | Hematocrit | 0 | Kidney | ||
b430-439 | Hemoglobin | 0 | Heart, kidney | ||
b430-439 | High sensitive C-reactive protein | 0 | Heart | ||
b430-439 | Interleukin levels | 2 | Heart, kidney | ||
b430-439 | Plasma norepinephrine | 0 | Heart | ||
b430-439 | Soluble cell adhesion molecules | 1 | Heart | ||
b430-439 | Total-homocysteine | 0 | Kidney | ||
b430-439 | Tumour necrosis factor-alpha | 2 | Heart | ||
B430-439 | Tumor necrosis factor receptor | 0 | Kidney | ||
b435 | Cytomegalovirus IgG status | 0 | Heart | ||
b435 | White blood cell levels | 0 | Heart | ||
b435 | Acute rejection episodes | 0 | Heart, lung | ||
Functions of the respiratory system (respiration functions) | b440 | Forced expiratory volume | 0 | Lung | |
functions) | b440 | Forced vital capacity | 1 | Heart | |
b440 | Maximum expiratory/inspiratory pressure | 0 | Heart | ||
b440 | Peak expiratory flow | 0 | Kidney | ||
b440 | Peak respiratory exchange ratio | 1 | Heart, kidney, liver, lung | ||
b440 | Respiratory compensation point | 0 | Heart | ||
b440 | Ventilatory reserve and capacity | 0 | Lung | ||
Functions of the respiratory system (respiration rate) | b4400 | CO2 production | 0 | Heart | |
b4400 | Oxygen uptake at anaerobic threshold | 0 | Lung | ||
b4400 | Peak ventilation | 2 | Heart, kidney | ||
b4400 | Peak VO2 | 13 | Heart, kidney, liver, lung | ||
b4400 | Ventilatory equivalent for carbon dioxide and oxygen | 1 | Heart | ||
Functions of the respiratory system (respiratory muscle functions) | b445 | Respiratory muscle force/strength | 1 | Heart, lung | |
Functions of the cardiovascular system (general physical endurance) | b4550 | Rating of perceived exertion | 0 | Heart, kidney, liver | |
Functions related to the digestive, metabolism and the endocrine system | b530 | Body mass index | 4 | Heart, kidney, liver | |
endocrine system | b530 | Body weight/mass | 3 | Heart, kidney, liver, lung | |
b530 | Fat mass/body fat | 3 | Heart, kidney, liver | ||
b530 | Fat-free mass | 1 | Heart | ||
b530 | Hip girth | 0 | Kidney | ||
b530 | Hip-waist ratio | 0 | Heart | ||
b530 | Lean tissue mass | 2 | Heart, kidney, liver | ||
b530 | Percent body fat | 2 | Heart, kidney, liver | ||
b530 | Visceral fat scale | 0 | Heart | ||
b530 | Waist girth | 0 | Kidney | ||
General metabolic functions, unspecified | b5400 | Basal metabolic rate | 0 | Heart | |
b5400 | Metabolic age | 0 | Heart | ||
General metabolic functions, other, specified | B5408 | Maximal metabolic units | 1 | Kidney | |
Functions related to metabolism and the endocrine system | b540-559 | Enzyme levels | 0 | Kidney | |
system | b540-559 | Fetuin A | 0 | Kidney | |
b540-559 | Oxidative stress-induced lipid peroxidation | 0 | Heart | ||
b540-559 | Serum insulin | 1 | Heart | ||
b540-559 | Serum metabolic and/or hematologic profile | 1 | Heart | ||
b540-559 | Vitamin B12 | 0 | Kidney | ||
b540-559 | Glycemic control parameters | 0 | Heart, kidney | ||
b540-559 | Muscle metabolic enzyme activity | 1 | Heart | ||
b545 | Body water | 0 | Heart | ||
b545 | Homeostasis model assessment | 0 | Heart | ||
Functions of the genitourinary and reproductive functions (urinary functions) | b610-639 | Glomerular filtration rate | 1 | Kidney | |
Neuromusculoskeletal and movement-related functions (muscle power functions) | b730 | Peak workload/power output | 1 | Heart, kidney, lung | |
b730 | Muscle strength | 7 | Heart, kidney, liver, lung | ||
b730-b749 | Muscle vasodilation | 1 | Heart | ||
b740 | Muscle endurance | 1 | Heart | ||
Body structure | Structures related to movement - additional musculoskeletal structures related to movement (bones) | s7700 | Bone mass | 0 | Heart |
s7700 | Bone mineral content | 1 | Heart, kidney, liver | ||
s7700 | Bone mineral density | 3 | Heart, kidney, liver, lung | ||
s7700 | Total bone calcium | 0 | Heart | ||
s7702 | Muscle composition (fibre types) | 1 | Heart | ||
Activities and participation | Mobility - walking and moving | d410 | STS-60 | 0 | Kidney |
participation | Mobility - walking and moving (walking) | d450 | Daily steps | 0 | Lung |
d450 | Daily walking time | 1 | Lung | ||
d450 | 6 Minute Walk Distance | 3 | Heart, liver, lung | ||
d450 | Anaerobic threshold | 1 | Heart, lung | ||
Mobility - walking and moving | d450-469 | Daily physical activity | 0 | Heart | |
d450-469 | Movement intensity | 0 | Lung | ||
d450-469 | Self-reported activity level | 0 | Kidney | ||
d450-469 | Time spent in moderate intense activities | 0 | Lung | ||
d450-469 | Duke Treadmill Score | 0 | Heart | ||
d450-469 | Exercise duration | 1 | Heart, kidney | ||
Managing diet and fitness | d5701 | Caloric intake | 0 | Heart | |
d5701 | Nutritional intake | 1 | Liver | ||
Major life areas (work and employment) | d840-859 | Employment status | 1 | Kidney | |
Environmental factors | Products or substances for personal consumption, other specified | e1108 | Smoking status | 0 | Kidney |
Drugs | e1101 | Immunosuppression use | 0 | Kidney | |
Questionnaires | DASI | 0 | Kidney | ||
Quality of Life Profile for Chronic Diseases Questionnaire | 1 | Lung | |||
SF-36 | 8 | Heart, kidney, liver, lung | |||
St. George’s Respiratory Questionnaire | 1 | Lung | |||
State-Trait Anxiety Inventory | 1 | Heart | |||
Beck Depression Inventory | 1 | Heart | |||
Hospital Anxiety and Depression Scale | 2 | Heart | |||
Visual Analog Scale (change in HRQoL) | 0 | Heart | |||
WHOQOL-BREF | 2 | Heart, kidney | |||
Not covered by ICF | Chronic Liver Disease Questionnaire | 1 | Liver | ||
Incidence of morbidity | 0 | Kidney, lung | |||
Adherence to training and follow-up | 2 | Kidney |
- Citation: Janaudis-Ferreira T, Mathur S, Konidis S, Tansey CM, Beaurepaire C. Outcomes in randomized controlled trials of exercise interventions in solid organ transplant. World J Transplant 2016; 6(4): 774-789
- URL: https://www.wjgnet.com/2220-3230/full/v6/i4/774.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i4.774